Previous studies have established that the expression of CD274/PD-L1 was associated with multiple signaling pathways, including IL-6/JAK/STAT3, PI-3K/AKT/mTOR, JAK/STAT, and WNT, which collectively influenced the tumor immune microenvironment. Here, CD274 is linked to neoplasm.